WILMINGTON, Del., Aug. 29, 2016 -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Rackspace Hosting, Inc. (“Rackspace” or the “Company”) relating to the sale of the Company to affiliates of private equity firm Apollo Global Management LLC (“Apollo”). On August 26, 2016, the two parties announced the signing of a definitive merger agreement pursuant to which Apollo will acquire Rackspace in a merger in a deal worth $4.3 billion. As a result of the merger, Rackspace shareholders are only anticipated to receive $32.00 per share in cash in exchange for each share of Rackspace.
Andrews & Springer’s investigation so far has revealed that the consideration Rackspace are expected to receive is inadequate. While the Company claims that shareholders will receive a premium for their shares, the merger price is only 6% above Rackspace’s August 25, 2016 closing price of $30.19 per share. In addition, the consideration is less than the $38.00 per share price target given by Cowen Company in August 2016, several weeks before the merger was announced. The $32.00 per share consideration is also 2.62% below Rackspace’s 52-week high of $32.84. Our investigation has also revealed that the process leading up to the announcement of the merger appears to have significant conflicts of interest thus making the process and consideration unfair.
If you own shares of Rackspace and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/rackspace-class-action-investigation or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.
Contact: Craig J. Springer, Esq. [email protected] Toll Free: 1-800-423-6013


Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



